These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22105447)

  • 1. Reduced pre-pregnancy proteinuria is associated with improving postnatal maternal renal outcomes in IgA nephropathy women.
    Oh HJ; Han SH; Yoo DE; Kim SJ; Park JT; Kim JK; Yoo TH; Kang SW; Choi KH
    Clin Nephrol; 2011 Dec; 76(6):447-54. PubMed ID: 22105447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study.
    Limardo M; Imbasciati E; Ravani P; Surian M; Torres D; Gregorini G; Magistroni R; Casellato D; Gammaro L; Pozzi C;
    Am J Kidney Dis; 2010 Sep; 56(3):506-12. PubMed ID: 20599307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy in women with immunoglobulin A nephropathy: are obstetrical complications associated with renal prognosis?
    Park S; Yoo KD; Park JS; Hong JS; Baek S; Park SK; Chin HJ; Na KY; Choi Y; Kim DK; Oh KH; Joo KW; Kim YS; Lee H
    Nephrol Dial Transplant; 2018 Mar; 33(3):459-465. PubMed ID: 28460070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pregnancy and Delivery on the Renal Function and the Prognosis of Patients with Chronic Kidney Disease Stage 3 Caused by Immunoglobulin A Nephropathy.
    Shimizu A; Takei T; Moriyama T; Itabashi M; Uchida K; Nitta K
    Intern Med; 2015; 54(24):3127-32. PubMed ID: 26666598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes.
    Imbasciati E; Gregorini G; Cabiddu G; Gammaro L; Ambroso G; Del Giudice A; Ravani P
    Am J Kidney Dis; 2007 Jun; 49(6):753-62. PubMed ID: 17533018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of kidney disease stage on pregnancy and delivery outcomes among patients with immunoglobulin A nephropathy.
    Shimizu A; Takei T; Moriyama T; Itabashi M; Uchida K; Nitta K
    Am J Nephrol; 2010; 32(5):456-61. PubMed ID: 20924168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy in IgA nephropathy.
    Abe S
    Kidney Int; 1991 Dec; 40(6):1098-102. PubMed ID: 1762310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study.
    Su X; Lv J; Liu Y; Wang J; Ma X; Shi S; Liu L; Zhang H
    Am J Kidney Dis; 2017 Aug; 70(2):262-269. PubMed ID: 28320554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the predictors for superimposed preeclampsia in patients with IgA nephropathy].
    Suetsugu Y; Tokudome G; Sugano N; Yoshizawa T; Endo S; Hara Y; Takane K; Kuriyama S; Hosoya T
    Nihon Jinzo Gakkai Shi; 2011; 53(8):1139-49. PubMed ID: 22351992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
    Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
    Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Outcomes of Pregnant Patients with Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis.
    Wang F; Lu JD; Zhu Y; Wang TT; Xue J
    Am J Nephrol; 2019; 49(3):214-224. PubMed ID: 30808834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gestation on renal function in gravida with IgA nephropathy.
    Nagai Y; Waschizawa Y; Suzuki T; Fushimi T; Hirata K; Kawamura S; Schiina K; Tanaka M; Maeda M
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):635-41. PubMed ID: 2795992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
    Liu Y; Ma X; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Am J Kidney Dis; 2014 Nov; 64(5):730-6. PubMed ID: 25134778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
    Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.